Elanders AB
At the 2021 Annual General Meeting, Elanders AB's nomination committee will propose Eva Elmstedt as a new member of the Board of Directors.
Eva Elmstedt, born in 1960, has a bachelor’s degree in Economics and Computer Science. She is currently Chairman of the Board of Proact IT Group and a member of the Boards of Addtech, Arjo, Semcon and Smart Eye. Eva Elmstedt has previously held senior positions at Nokia Networks, Nokia Siemens Networks, Ericsson, the mobile operator 3 and Semcon, among others.
The nomination committee further proposes re-election of the existing board members;
- Carl Bennet, chairman
- Dan Frohm
- Erik Gabrielson
- Cecilia Lager
- Anne Lenerius
- Magnus Nilsson
- Johan Stern
- Caroline Sundewall
Pam Fredman and Linus Karlsson declines re-election.
The Board also comprises the following employees’ representatives, elected by the employees;
- Martin Schubach
- Martin Afzelius
- Johan Lidbrink, deputy member
For further information, please contact the nomination committee's chairman Carl Bennet on telephone +46 31 741 64 00 or via e-mail valberedning@elanders.com.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ALK Abello19.12.2025 22:46:46 CET | Press release
Major shareholder announcement
ALK Abello19.12.2025 22:46:46 CET | Pressemeddelelse
Storaktionærmeddelelse
Zealand Pharma19.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Boehringer Ingelheim Limited19.12.2025 21:10:00 CET | Press release
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
Novartis Pharma AG19.12.2025 20:30:06 CET | Press release
Novartis and US government reach agreement on lowering drug prices in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
